Skopos Labs, Inc. Collegium Pharmaceutical, Inc Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 529 shares of COLL stock, worth $18,308. This represents 0.0% of its overall portfolio holdings.
Number of Shares
529
Previous 529
-0.0%
Holding current value
$18,308
Previous $15,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding COLL
# of Institutions
241Shares Held
36.4MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$201 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$109 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$91.4 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$77.8 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.58MShares$54.9 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.18B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...